Caranx Medical today announced it completed its first robotic assisted transcatheter aortic valve implantation.
The assisted heart valve implantation in an animal was successfully performed by Dr. Stéphane Lopez, Caranx CMO Dr. Eric Sejor, Caranx CTO Pierre Berthet-Rayne and the Caranx team.
“This groundbreaking achievement is the result of hard teamwork. At Caranx Medical, we are dedicated to improving patients’ lives through true innovation. This successful transcatheter robotic aortic valve implantation marks the first step toward a new generation of intelligent robots guided by AI, set to transform healthcare as we know it,” Berthet-Rayne said in a news release.
Nice, France-based Caranx Medical developed the robotic solution, TAVI-Pilot, for aortic valve replacement. The robot can make an artery puncture and then, based on real-time imaging, control the navigation of the instruments to the heart before delivering the prosthetic aortic valve to a location determined in the pre-operative planning. The procedure is completed under the supervision of the clinician.
“This is a major achievement by the Caranx team in the past months. However, at Caranx Medical, we’re not just stopping at Aortic valve replacement. Our vision extends to developing our Artificial Intelligence Platform, currently containing more than 5,000 of annotated multimodality images of CT, fluoroscopy, echo, reports, etc. used to feed our AI algorithms and to revolutionize other endovascular indications, such as mitral and tricuspid valve replacements or even other endoluminal procedures, reshaping the landscape of interventional medicine,” CEO Jorgen Hansen said.
